Loading clinical trials...
Loading clinical trials...
This is a placebo-controlled, randomized, double-blind, parallel arm, multicenter, dose-ranging phase IIb trial to assess glycemic and weight loss efficacy and safety of BMS-646256 in overweight and o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Solvay Pharmaceuticals
Collaborators
NCT06830096 · Obesity and Type 2 Diabetes
NCT06890169 · Obesity and Type 2 Diabetes, NAFLD - Non-Alcoholic Fatty Liver Disease, and more
NCT06599047 · Obesity and Type 2 Diabetes, Bariatric Patients Undergoing Bariatric Surgery, and more
NCT06800794 · Obesity and Type 2 Diabetes
NCT06607068 · Obesity and Type 2 Diabetes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions